Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. September 2015 08:00 ET | Quelle: Zogenix, Inc.

Zogenix to Participate in the Wells Fargo 2015 Healthcare Conference

SAN DIEGO, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, today announced...
10. August 2015 16:01 ET | Quelle: Zogenix, Inc.

Zogenix Provides Corporate Update and Reports Second Quarter 2015 Financial Results

SAN DIEGO, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders,...
05. August 2015 08:00 ET | Quelle: Zogenix, Inc.

Zogenix Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

SAN DIEGO, Aug. 5, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing unique therapies for the treatment of central nervous system (CNS)...
03. August 2015 08:00 ET | Quelle: Zogenix, Inc.

Zogenix to Release Second Quarter 2015 Financial Results and Host Conference Call & Webcast on August 10

SAN DIEGO, Aug. 3, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders,...
30. Juli 2015 08:00 ET | Quelle: Zogenix, Inc.

Zogenix Prices Public Offering of Common Stock

SAN DIEGO, July 30, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing unique therapies for the treatment of central nervous system (CNS)...
28. Juli 2015 16:38 ET | Quelle: Zogenix, Inc.

Zogenix Announces Proposed Public Offering of 3,800,000 Shares of Common Stock

SAN DIEGO, July 28, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing unique therapies for the treatment of central nervous system (CNS)...
07. Juli 2015 08:00 ET | Quelle: Zogenix, Inc.

Zogenix to Host Key Opinion Leader Meeting Tuesday, July 14, in New York City

SAN DIEGO, July 7, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing unique therapies for the treatment of central nervous system (CNS)...
06. Juli 2015 08:30 ET | Quelle: Zogenix, Inc.

Zogenix Expands Senior Leadership Team to Further Drive Strategic Focus on CNS Disorders and Orphan Drug Development

SAN DIEGO, July 6, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders,...
06. Juli 2015 08:00 ET | Quelle: Zogenix, Inc.

Zogenix to Participate in Cantor Fitzgerald Healthcare Conference

SAN DIEGO, July 6, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing unique therapies for the treatment of central nervous system (CNS)...
18. Juni 2015 16:18 ET | Quelle: Zogenix, Inc.

Zogenix Announces Shareholders and Board of Directors Approve Reverse Stock Split

SAN DIEGO, June 18, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders,...

Vorherige Seite

Nächste Seite